Healthcare provider profile · identity verified

Kimber M Gauthier, MD

Family Practice · ESCANABA, MI · NPI 1871587709

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	613	136
Atorvastatin Calcium	Atorvastatin Calcium	595	163
Lisinopril	Lisinopril	565	140
Rosuvastatin Calcium	Rosuvastatin Calcium	451	117
Amlodipine Besylate	Amlodipine Besylate	441	118
Omeprazole	Omeprazole	417	129
Losartan Potassium	Losartan Potassium	335	92
Metoprolol Succinate	Metoprolol Succinate	262	73
Simvastatin	Simvastatin	243	61
Metoprolol Tartrate	Metoprolol Tartrate	218	65
Montelukast Sodium	Montelukast Sodium	211	57
Gabapentin	Gabapentin	200	45
Sertraline Hcl	Sertraline Hcl	195	45
Ozempic	Semaglutide	174	43
Pantoprazole Sodium	Pantoprazole Sodium	164	48
Fluticasone Propionate	Fluticasone Propionate	162	54
Chlorthalidone	Chlorthalidone	146	44
Venlafaxine Hcl Er	Venlafaxine Hcl	143	39
Metformin Hcl Er	Metformin Hcl	137	36
Famotidine	Famotidine	136	42
Eliquis	Apixaban	135	37
Furosemide	Furosemide	135	33
Duloxetine Hcl	Duloxetine Hcl	133	31
Potassium Chloride	Potassium Chloride	124	36
Jardiance	Empagliflozin	120	30
Albuterol Sulfate Hfa	Albuterol Sulfate	112	61
Allopurinol	Allopurinol	105	27
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	103	26
Trazodone Hcl	Trazodone Hcl	102	32
Clopidogrel	Clopidogrel Bisulfate	99	28
Hydrochlorothiazide	Hydrochlorothiazide	97	29
Escitalopram Oxalate	Escitalopram Oxalate	93	30
Lovastatin	Lovastatin	93	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	23
Pravastatin Sodium	Pravastatin Sodium	91	29
Meloxicam	Meloxicam	89	29
Metformin Hcl	Metformin Hcl	85	26
Fluoxetine Hcl	Fluoxetine Hcl	80	18
Buspirone Hcl	Buspirone Hcl	78	27
Spironolactone	Spironolactone	78	21
Esomeprazole Magnesium	Esomeprazole Magnesium	75	21
Glipizide Er	Glipizide	67	19
Tamsulosin Hcl	Tamsulosin Hcl	67	17
Xarelto	Rivaroxaban	63	14
Citalopram Hbr	Citalopram Hydrobromide	62	14
Carvedilol	Carvedilol	56	16
Ezetimibe	Ezetimibe	56	20
Synthroid	Levothyroxine Sodium	56	13
Mounjaro	Tirzepatide	54	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	54	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	19
Enalapril Maleate	Enalapril Maleate	49	13
Mirtazapine	Mirtazapine	49	12
Paroxetine Hcl	Paroxetine Hcl	49	12
Triamcinolone Acetonide	Triamcinolone Acetonide	49	32
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	17
Prednisone	Prednisone	48	21
Bupropion Xl	Bupropion Hcl	46	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	14
Alendronate Sodium	Alendronate Sodium	44	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	11
Donepezil Hcl	Donepezil Hcl	41	14
Pregabalin	Pregabalin	41	suppressed
Nystatin	Nystatin	39	22
Warfarin Sodium	Warfarin Sodium	39	11
Solifenacin Succinate	Solifenacin Succinate	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Tramadol Hcl	Tramadol Hcl	35	suppressed
Sodium Chloride	0.9 % Sodium Chloride	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Estradiol	Estradiol	32	suppressed
Jantoven	Warfarin Sodium	32	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	suppressed
Symbicort	Budesonide/Formoterol Fumarate	31	13
Alprazolam	Alprazolam	30	18
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Finasteride	Finasteride	29	suppressed
Valsartan	Valsartan	29	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	28	suppressed
Sucralfate	Sucralfate	28	11
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Vilazodone Hcl	Vilazodone Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Atenolol	Atenolol	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	12
Lansoprazole	Lansoprazole	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Topiramate	Topiramate	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	12
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	14
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	19	suppressed
Methylprednisolone	Methylprednisolone	19	15
Nitroglycerin	Nitroglycerin	19	15
Cephalexin	Cephalexin	18	18
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Epinephrine	Epinephrine	17	16
Fenofibrate	Fenofibrate,micronized	17	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Glipizide	Glipizide	15	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nystop	Nystatin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Verapamil Hcl	Verapamil Hcl	14	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Methimazole	Methimazole	13	suppressed
Ramipril	Ramipril	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Vienva	Levonorgestrel/Ethin.Estradiol	12	suppressed
Belsomra	Suvorexant	11	suppressed
Diazepam	Diazepam	11	suppressed
Unithroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error